Why BioRestorative Therapies Stock Is Moving Higher Thursday
Why BioRestorative Therapies Stock Is Moving Higher Thursday
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Thursday after the company said it has engaged in licensing discussions with a undisclosed commercial regenerative medicine company.
BioRestorative Therapies，Inc.（納斯達克：BRTX）股票週四上漲，因該公司表示已經與一家未披露商業再生醫學公司進行了許可討論。
What Happened: BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions with an regenerative medicine company related to its ThermoStem Metabolic Disease Program intellectual property.
事件經過：BioRestorative Therapies週四市場開放之前宣佈，該公司與一家再生醫學公司就其ThermoStem代謝疾病方案知識產權進行了實質性授權討論。
Research conducted in collaboration with the University of Utah School of Medicine has demonstrated that certain stem cells with brown adipogenic potential could represent a new way of treating obesity and related metabolic disorders.
與猶他州醫學院合作的研究表明，具有褐色脂肪生成潛能的某些幹細胞可能代表了治療肥胖和相關代謝疾病的新途徑。
Currently, there is no guarantee that a license agreement will be made between the two companies.
目前，兩家公司之間有無許可協議的保證。
Related Link: Candel Therapeutics' (NASDAQ:CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
相關鏈接：Candel Therapeutics的（納斯達克：CADL）enLIGHTEN Discovery平台旨在應對腫瘤微環境的複雜性。
BRTX Price Action: At the time of writing, BioRestorative shares are trading 29% higher at $1.75 per data from Benzinga Pro.
BRTX價格走勢：截至撰稿時，BioRestorative股票交易上漲29％，股價爲1.75美元，根據Benzinga Pro數據。
Image: Image via Shutterstock
圖片：圖片通過shutterstock獲取。
譯文內容由第三人軟體翻譯。